News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
110 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27610)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Policy
3Shape Responds to Align Technology’s Sudden Termination of Invisalign Interoperability
This is despite the fact that the interoperability has absolutely no legal link to the patent infringement allegations against 3Shape, which are completely unfounded and without merit.
December 20, 2017
·
2 min read
Genetown
Tarveda Therapeutics to Present at the 2018 Biotech Showcase
Tarveda Therapeutics announced that Drew Fromkin, President and Chief Executive Officer, will present at the 10th Annual Biotech Showcase, occurring January 8-10, 2018 at the Hilton Union Square in San Francisco.
December 20, 2017
·
2 min read
Business
ORIC Has Appointed Rich Heyman, PhD as Acting CEO and Leonard Reyno, MD as CMO
Dr. Rich Heyman has over 25 years of biopharma experience and previously served as CEO of Seragon.
December 20, 2017
·
3 min read
Tessa Therapeutics Lands $80M Financing to Advance Clinical Pipeline
The $80M financing round led by Temasek and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.
December 20, 2017
·
3 min read
Business
Actelion Spin Out Joins Forces With Roche on Cancer Immunotherapy
Idorsia today announced that it has entered into a research collaboration that provides Roche with an exclusive option right to develop and market first-in-class compounds for a promising new approach in the field of cancer immunotherapy.
December 20, 2017
·
1 min read
Creative Medical Technology Release: Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism
Creative Medical Technology provides the following discussion on a recent US News and World Report article addressing advances of adult stem cells and its own patented stem cell technologies.
December 20, 2017
·
4 min read
Business
Renovion Elects Derek Winstanly as Chairman of Board of Directors
Dr. Winstanly served as the Executive Vice President, Chief Customer and Governance Officer of Quintiles Transnational, November 2011- 2015.
December 20, 2017
·
2 min read
Business
Acticor Biotech Announces Appointment of Dr Yannick Plétan as Chief Medical Officer
He will report to Gilles Avenard, CEO of Acticor Biotech and be responsible for leading all clinical development and medical affairs at Acticor Biotech.
December 20, 2017
·
2 min read
Pharm Country
Applied DNA Announces $4.8 Million Registered Direct Offering of Common Stock
Each share of common stock is being sold together with a warrant to purchase one share of common stock at a combined effective price to the public of $1.75.
December 20, 2017
·
4 min read
Business
Mentice Acquires Endovascular Business From Medical Simulation Corporation
Under the agreement, Mentice will acquire the assets of the MSC’s Medical Products division in a share based transaction.
December 20, 2017
·
2 min read
Previous
3 of 11
Next